866-997-4948(US-Canada Toll Free)

Chronic Pain Global Clinical Trials Review, H2, 2015

Published By :

GlobalData

Published Date : Dec 2015

Category :

Pharmaceutical

No. of Pages : 396 Pages

Chronic Pain Global Clinical Trials Review, H2, 2015

Summary

GlobalDatas clinical trial report, Chronic Pain Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chronic Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Chronic Pain Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Chronic Pain 31
Dec 09, 2015: Relmada Therapeutics Announces Positive Topline Results for Proof-of-Concept Study with BuTab 31
Dec 09, 2015: Cara Therapeutics Announces Positive Top-Line Results From Phase 2a Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Knee or Hip 31
Dec 09, 2015: Relmada Therapeutics Announces Positive Topline Results for Proof-of-Concept Study with BuTab 32
Clinical Trial Profile Snapshots 33
Appendix 393
Abbreviations 393
Definitions 393
Research Methodology 394
Secondary Research 394
About GlobalData 395
Contact Us 395
Disclaimer 395
Source 396

List of Tables
Chronic Pain Therapeutics, Global, Clinical Trials by Region, 2015* 6
Chronic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Chronic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Chronic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Chronic Pain Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Chronic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Chronic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Chronic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Chronic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Chronic Pain Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Chronic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Chronic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Chronic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Chronic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Chronic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Chronic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Chronic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Chronic Pain Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Chronic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Chronic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Chronic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Chronic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Chronic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Chronic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Chronic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Chronic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Chronic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Chronic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Chronic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Chronic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Chronic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Chronic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Chronic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Chronic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Chronic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Chronic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Chronic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 394

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Menotropin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    Menotropin is a substance used for the treatment for infertility cases. Menotropin is also called as (human menopausal gonadotropin or HMG) consisting of equal proportion of follicle stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are extracted from urine of post menopausal women. Menotropin is extensively used for triggering the production of FSH and LH hormones in the body for stimulating ovaries to make eggs. Hence, it...

  • Cell Based Assays Market - Global Industry Analysis, Market Share, Size, Growth, Trends, And Forecast, 2012 - 2018

    The term ‘cell based assay’ refers to the use of live cells to test the effect of a foreign substance on the functionalities and behavior of a cell. These cell based assays are the most accurate method of cell testing, due to the fact that live cells are utilized for experiments.  It is used for determining factors like cell toxicity, cell proliferation, motility, and cell morphology. The global market for cell based assays is ...

  • Alcohol Excipients Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019

    Alcohol excipients are inactive substances generally used as functional additives in pharmaceuticals. Excipient is inactive substance which is used with the active ingredients to improve absorption in body. Excipients also help to control the release of the active substances over a period of time if the treatment demands. As excipients are added to the formulations that contain active ingredients, they are also called bulking agents, fillers or d...